Weiwei Chen Email
Independent Non-Executive Direector, Audit Committee Chair @ HARBOUR BIOMED
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Weiwei Chen Location
- China
Weiwei Chen Work
- Board Senior Advisor @ Dayao Drinks (a KKR invested company) (March 2026 - Present)
- Independent Non-Executive Direector, Audit Committee Chair @ (January 2025 - Present)
- Non-Executive Director @ (June 2021 - December 2024)
- Independent Non-Executive Director, Audit Committee Chair @ (December 2020 - June 2021)
- Board Advisor @ (April 2024 - Present)
- Audit Committee Chair @ (March 2024 - Present)
- Independent Non-Executive Director @ (November 2021 - Present)
- Senior Advisor @ KKR Asia Limited (July 2023 - Present)
- Board Senior Advisor @ PHARMPLUS (a KKR invested company) (May 2021 - Present)
- Business Advisor @ Cross Ocean Group (a commercial real estate company) (June 2022 - March 2026)
- Independent Non-Executive Director @ (April 2022 - August 2024)
- Vice President, Chief Financial Officer @ (June 2015 - December 2020)
- Chief Financial Officer, China Division @ (July 2012 - May 2015)
- Chief Financial Officer, Asia @ (April 2011 - June 2012)
- Chief Financial Officer, China @ (February 2004 - March 2011)
- Finance Director @ (October 1999 - January 2004)
- Manager - Business Planning and Analysis @ (February 1999 - September 1999)
- Senior Financial Analyst - Capital Planning @ (April 1997 - January 1999)
- Senior Auditor @ (October 1993 - March 1997)
Weiwei Chen Education
- Rutgers University
Master of Business Administration (MBA)
- University of Illinois Urbana-Champaign
Bachelor of Science (BS) (Accounting)
Weiwei Chen Skills
- Sarbanes-Oxley Act
- Business Planning
- Internal Controls
- Financial Audits
- Corporate Finance
- Analysis
- Cash Flow
- Auditing
- Cross-functional Team Leadership
- Strategy
- Financial Analysis
- Accounting
- Management
- Finance
- Forecasting
- Business Strategy
- Strategic Planning
- Cross Functional Team Leadership
- Sarbanes Oxley Act
- Marketing
- Business Development
Weiwei Chen Summary
- Weiwei Chen, based in China, is currently a Independent Non-Executive Direector, Audit Committee Chair at HARBOUR BIOMED. Weiwei Chen brings experience from previous roles at Dayao Drinks (a KKR invested company), HARBOUR BIOMED and Hong Kong Maxim's Group. Weiwei Chen holds a Master of Business Administration (MBA) @ Rutgers University. With a robust skill set that includes Sarbanes-Oxley Act, Business Planning, Internal Controls, Financial Audits, Corporate Finance and more. Weiwei Chen has 3 emails on RocketReach.
Looking for a different Weiwei Chen?
Find contact details for 700 million professionals.
Others Named Weiwei Chen
Weiwei Chen
Executive Director
Hong Kong
Weiwei Chen
Principal Engineer
Somerville, MA, US
Weiwei Chen
VP of Product Management
Taipei City, Taiwan, Taiwan
Weiwei Chen
Vice President of Client Success
Vancouver, BC, CA
Weiwei Chen
Director of Business Development
Palo Alto, CA, US
Weiwei Chen
Managing Director
Shanghai, China
Weiwei Chen
Relationship Manager
Switzerland
Top HARBOUR BIOMED Employees
Adam Zong
President
Princeton, NJ, US
Ian Liu
SVP, Global Head of Legal
Boston, MA, US
Sean Zhang
Chief Medical Officer, Harbour Medical
United States
Jenny Xie
CSO, Immunology
Shanghai, China
Mike Patten
Chief Strategy Officer
New York, NY, US
Xiaolu Tao
Chief Development Officer (CDO)
United States
Yiping Rong
CSO, Executive Board of Director
Shanghai, China
Yu Wang
Director of Business Development
Shanghai, China
Jingsong Wang
Founder and CEO
Cambridge, MA, US
Bob Zhang
President, Metabolic Disease Franchise
San Diego, CA, US
Ben Chih
CSO, Neuroscience
Millbrae, CA, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co